Mirati Therapeutics, Inc. (MRTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
24-Jan-23 4:03 PM
View: 
Sharp Shalini
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----89%
4.97K to 9.41K
24-Jan-23 4:00 PM
View: 
Fuchs Henry J
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----74%
6.02K to 10.46K
24-Jan-23 4:00 PM
View: 
Meek David D.
Chief Executive Officer
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 89,379----145%
61.79K to 151.17K
24-Jan-23 4:00 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----74%
6.02K to 10.46K
24-Jan-23 4:00 PM
View: 
Martinez Maria E
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----74%
6.02K to 10.46K
24-Jan-23 4:20 PM
View: 
Davis Aaron I.
Director
10% Owner
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----10%
43.07K to 47.52K
24-Jan-23 4:19 PM
View: 
Johnson Craig A
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----74%
6.02K to 10.46K
24-Jan-23 4:17 PM
View: 
Hasnain Faheem
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 6,333----73%
8.72K to 15.05K
24-Jan-23 4:00 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 26,864----27%
97.88K to 124.74K
24-Jan-23 4:18 PM
View: 
Cherrington Julie M
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----100%
0 to 4.44K
24-Jan-23 4:00 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 36,394----77%
47.22K to 83.62K
24-Jan-23 4:20 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 4,444----3%
168.78K to 173.22K
24-Jan-23 4:00 PM
View: 
Stelzer Laurie
CFO
Mirati Therapeutics, Inc. (MRTX) 20-Jan-23Grant 26,864----46%
57.8K to 84.66K
20-Jan-23 9:20 AM
View: 
Cherrington Julie M
Director
Mirati Therapeutics, Inc. (MRTX) 18-Jan-23Sale (Planned) 2,546$44.66$113,704.00(100%)
2.55K to 0
19-Jan-23 9:45 AM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 17-Jan-23Sale 2,245$42.38$95,142.00(2%)
100.12K to 97.88K
19-Jan-23 9:45 AM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 17-Jan-23Sale 1,566$42.38$66,366.00(3%)
48.79K to 47.22K
19-Jan-23 9:45 AM
View: 
Meek David D.
Chief Executive Officer
Director
Mirati Therapeutics, Inc. (MRTX) 17-Jan-23Sale 3,179$42.38$134,715.00(5%)
64.97K to 61.79K
10-Jan-23 5:00 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 09-Jan-23Sale 2,088$45.37$94,732.60(4%)
50.88K to 48.79K
05-Jan-23 5:13 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 04-Jan-23Sale 1,949$46.60$90,823.40(2%)
102.07K to 100.12K
05-Jan-23 5:13 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 04-Jan-23Sale 3,648$46.60$169,997.00(2%)
172.43K to 168.78K
21-Dec-22 9:20 PM
View: 
Meek David D.
Chief Executive Officer
Director
Mirati Therapeutics, Inc. (MRTX) 21-Dec-22Sale 4,616$40.41$186,552.00(7%)
69.59K to 64.97K
21-Dec-22 9:20 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 21-Dec-22Sale 3,248$40.41$131,266.00(6%)
54.13K to 50.88K
21-Dec-22 9:21 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 21-Dec-22Sale 9,092$40.42$367,469.00(5%)
181.52K to 172.43K
21-Dec-22 9:20 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 19-Dec-22Grant 19,149----55%
34.98K to 54.13K
21-Dec-22 9:21 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 19-Dec-22Grant 53,618----42%
127.9K to 181.52K
21-Dec-22 9:20 PM
View: 
Meek David D.
Chief Executive Officer
Director
Mirati Therapeutics, Inc. (MRTX) 19-Dec-22Grant 35,425----104%
34.16K to 69.59K
20-Dec-22 4:02 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 16-Dec-22Sale 2,410$43.00$103,624.00(2%)
104.48K to 102.07K
05-Dec-22 5:00 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 02-Dec-22Sale 1,726$90.19$155,667.00(2%)
106.21K to 104.48K
28-Nov-22 7:01 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 28-Nov-22Planned Option Sale 69,256$100.00$6,925,600.00(35%)
197.16K to 127.9K
28-Nov-22 7:01 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 28-Nov-22Option Exercise 69,256$17.41$1,205,750.0054%
127.9K to 197.16K
08-Nov-22 6:00 PM
View: 
Sandler Alan B.
Chief Medical Officer
Mirati Therapeutics, Inc. (MRTX) 07-Nov-22Grant 40,000----100%
0 to 40.0K
09-Sep-22 5:35 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 07-Sep-22Grant 19,149----22%
86.94K to 106.09K
16-Aug-22 4:15 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 12-Aug-22Option Sale 10,000$85.49$854,899.00(62%)
16.02K to 6.02K
16-Aug-22 4:15 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 12-Aug-22Option Exercise 10,000$27.00$270,000.00166%
6.02K to 16.02K
03-Jun-22 5:56 PM
View: 
Stelzer Laurie
CFO
Mirati Therapeutics, Inc. (MRTX) 01-Jun-22Grant 57,798----100%
0 to 57.8K
14-Jun-22 4:35 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 23-May-22Sale 624$63.54$39,649.00(< 1%)
87.43K to 86.8K
14-Feb-22 4:51 PM
View: 
Fuchs Henry J
Director
Mirati Therapeutics, Inc. (MRTX) 11-Feb-22Option Exercise 11,000$20.54$225,940.00183%
6.02K to 17.02K
14-Feb-22 4:51 PM
View: 
Fuchs Henry J
Director
Mirati Therapeutics, Inc. (MRTX) 11-Feb-22Planned Option Sale 11,000$105.61$1,161,720.00(65%)
17.02K to 6.02K
20-Jan-22 4:57 PM
View: 
Cherrington Julie M
Director
Mirati Therapeutics, Inc. (MRTX) 19-Jan-22Market Sale (Planned) 1,475$116.07$171,203.00(37%)
4.02K to 2.55K
(7%)
18-Jan-22 8:33 PM
View: 
Christensen Jamie
EVP, Chief Scientific Officer
Mirati Therapeutics, Inc. (MRTX) 18-Jan-22Sale 627$120.51$75,557.70(< 1%)
88.06K to 87.43K
18-Jan-22 8:34 PM
View: 
Reed Vickie S
SVP, Chief Accounting Officer
Mirati Therapeutics, Inc. (MRTX) 18-Jan-22Sale 533$120.48$64,217.20(3%)
15.9K to 15.37K
18-Jan-22 8:32 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 18-Jan-22Option Sale 2,517$120.48$303,253.00(2%)
130.42K to 127.9K
18-Jan-22 8:32 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 18-Jan-22Option Exercise 3,703$27.00$99,981.003%
126.71K to 130.42K
18-Jan-22 8:32 PM
View: 
Hickey Benjamin
EVP, Chief Commercial Officer
Mirati Therapeutics, Inc. (MRTX) 18-Jan-22Sale 627$120.48$75,542.70(2%)
35.6K to 34.98K
18-Jan-22 8:34 PM
View: 
Reed Vickie S
SVP, Chief Accounting Officer
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 5,377----51%
10.53K to 15.9K
18-Jan-22 6:21 PM
View: 
Carter Bruce L A
Director
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 2,546----73%
3.48K to 6.02K
18-Jan-22 8:32 PM
View: 
Baum Charles M
President,Founder,Head of R&D
Director
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 25,543----25%
101.17K to 126.71K
18-Jan-22 6:21 PM
View: 
Fuchs Henry J
Director
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 2,546----73%
3.48K to 6.02K
18-Jan-22 6:17 PM
View: 
Davis Aaron I.
Director
10% Owner
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 2,546----6%
40.53K to 43.07K
18-Jan-22 6:20 PM
View: 
Johnson Craig A
Director
Mirati Therapeutics, Inc. (MRTX) 14-Jan-22Grant 2,546----73%
3.48K to 6.02K